el Mouaaouy A, Becker H D, Schlief R, Kuhlo C, Portas C
Chirurgische Universitätsklinik, Tübingen, Federal Republic of Germany.
Surg Endosc. 1990;4(2):114-7. doi: 10.1007/BF00591273.
The present animal experimental study showed that intraoperative hepatic ultrasonography using an echo contrast medium can visualize small hepatomas (with a diameter of between 3 and 15 mm) induced in the rat liver, although they were not recognizable with plain ultrasonography. A homogeneous increase in the echogenicity of the liver tissue was achieved by using an echo contrast medium (Echovist) based on galactose microparticles. Self-made bubble preparations such as those used in echocardiography were far less effective. When the dosage was optimal (0.01-0.003 ml/g liver weight with concentrations of 200 and 300 mg/ml Echovist), homogeneous contrast enhancement of the liver was achieved for at least 10 min after a single bolus injection via all routes of contrast administration (hepatic artery, portal vein, bile duct). As a result, hepatomas appeared as hypodense formations (portal vein and bile duct) or as hyperdense zones (hepatic artery).
目前的动物实验研究表明,使用超声造影剂的术中肝脏超声检查能够使大鼠肝脏中诱发的小肝癌(直径为3至15毫米)显影,尽管普通超声检查无法识别这些小肝癌。基于半乳糖微粒的超声造影剂(Echovist)可使肝脏组织的回声均匀增强。自制的气泡制剂(如用于超声心动图的制剂)效果要差得多。当剂量最佳时(肝脏重量0.01 - 0.003毫升/克,Echovist浓度为200和300毫克/毫升),通过所有造影剂给药途径(肝动脉、门静脉、胆管)单次推注后,肝脏至少10分钟内实现均匀的造影剂增强。结果,肝癌表现为低密度区(门静脉和胆管)或高密度区(肝动脉)。